Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action
暂无分享,去创建一个
[1] R. Beck,et al. HbA1c Levels in Type 1 Diabetes from Early Childhood to Older Adults: A Deeper Dive into the influence of technology and socio-economic status on HbA1c in the T1D Exchange Clinic Registry Findings. , 2020, Diabetes technology & therapeutics.
[2] T. Hansen,et al. Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow‐up study , 2015, Diabetic medicine : a journal of the British Diabetic Association.
[3] Korey K Hood,et al. Association Between Adherence and Glycemic Control in Pediatric Type 1 Diabetes: A Meta-analysis , 2009, Pediatrics.
[4] 7. Diabetes Technology: Standards of Medical Care in Diabetes-2021. , 2020, Diabetes care.
[5] M. Chin,et al. Social Determinants of Health and Diabetes: A Scientific Review , 2020, Diabetes care.
[6] R. Wachter,et al. Focusing on Digital Health Equity. , 2021, JAMA.
[7] D. Kruger,et al. Current Eligibility Requirements for CGM Coverage Are Harmful, Costly, and Unjustified , 2020, Diabetes technology & therapeutics.
[8] B. Buckingham,et al. Closed loop control in adolescents and children during winter sports: Use of the Tandem Control‐IQ AP system , 2019, Pediatric diabetes.
[9] Gregory P. Forlenza,et al. Six months of hybrid closed loop in the real‐world: An evaluation of children and young adults using the 670G system , 2019, Pediatric diabetes.
[10] R. Rikard,et al. Examining health literacy disparities in the United States: a third look at the National Assessment of Adult Literacy (NAAL) , 2016, BMC Public Health.
[11] W. Maier,et al. A Decade of Disparities in Diabetes Technology Use and HbA1c in Pediatric Type 1 Diabetes: A Transatlantic Comparison , 2020, Diabetes care.
[12] Korey K Hood,et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies , 2018, Pediatric diabetes.
[13] Cde,et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. , 2020, JAMA.
[14] C. de Beaufort,et al. Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry , 2016, Pediatric diabetes.
[15] M. Desai,et al. Improving Clinical Outcomes in Newly Diagnosed Pediatric Type 1 Diabetes: Teamwork, Targets, Technology, and Tight Control—The 4T Study , 2020, Frontiers in Endocrinology.
[16] O. Kordonouri,et al. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes , 2017, JAMA.
[17] R. Beck,et al. Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes. , 2013, Diabetes technology & therapeutics.
[18] E. Bass,et al. Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus , 2012, Annals of Internal Medicine.
[19] T. Danne,et al. Reduction in Diabetic Ketoacidosis and Severe Hypoglycemia in Pediatric Type 1 Diabetes During the First Year of Continuous Glucose Monitoring: A Multicenter Analysis of 3,553 Subjects From the DPV Registry , 2020, Diabetes Care.
[20] GrahamClaudia. Continuous Glucose Monitoring and Global Reimbursement: An Update. , 2017 .
[21] B. Perkins,et al. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. , 2017, The lancet. Diabetes & endocrinology.
[22] O. Cinek,et al. Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the ČENDA registry , 2021, Pediatric diabetes.
[23] F. Huang,et al. Artificial Pancreas as an Effective and Safe Alternative in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis , 2018, Diabetes Therapy.
[24] David M Maahs,et al. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018. , 2019, Diabetes technology & therapeutics.
[25] C. Graham. Continuous Glucose Monitoring and Global Reimbursement: An Update. , 2017, Diabetes technology & therapeutics.
[26] D. Maahs,et al. Barriers to Technology Use and Endocrinology Care for Underserved Communities With Type 1 Diabetes , 2021, Diabetes Care.
[27] R. Hovorka,et al. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis , 2018, British Medical Journal.
[28] D. Maahs,et al. Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance , 2020, Pediatric diabetes.
[29] A. Brorsson,et al. Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case–control study , 2015, Pediatric diabetes.
[30] Carolyn B. Yucha,et al. Continuous Glucose Monitors , 2014, Journal of diabetes science and technology.